NCT01116570

Brief Summary

It is now accepted that physical activity is not deleterious in myopathies, including muscular dystrophies. In patients suffering from facioscapulohumeral dystrophy (FSHD), aerobic training has been reported to be associated to physiological and functional positive effects without alteration in quality of life. The review papers from Van der Kooi et al. (2005), Cup et al. (2007) and Féasson et al. (2010) suggest that the combination of endurance and strength training is even more relevant. Only a few controlled and randomized studies have been conducted on this topic. The impact of such training programs on the skeletal muscle regenerative capacities has not been yet addressed. Moreover, due to the fact that training programs are mainly performed on short-term supervised periods, there is a lack of knowledge regarding long-term effects, patient's autonomy and whether or not regular exercise practice can be maintained in patient's daily life. Also, only a few experiments have reported an integrative view of the potential benefits of such programs on functional, biological and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 5, 2010

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2010

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

April 1, 2015

Status Verified

March 1, 2015

Enrollment Period

4.3 years

First QC Date

April 28, 2010

Last Update Submit

March 31, 2015

Conditions

Keywords

Muscular DystrophyFacioscapulohumeralPhysical trainingExercise

Outcome Measures

Primary Outcomes (1)

  • maximal oxygen uptake (VO2max)

    VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle

    Week 24

Secondary Outcomes (5)

  • Questionnaire of quality of life

    Day 0, Week 6, Week 12, Week 18 and Week 24

  • Biopsy

    Day 0 and Week 24

  • maximal oxygen uptake (VO2max)

    Week 6, Week 12 and Week 18

  • Questionnaire of subjective fatigue

    Day 0, Week 6, Week 12, Week 18 and Week 24

  • nuclear magnetic resonance imaging

    Inclusion

Study Arms (2)

Physical training

EXPERIMENTAL

The training will consist in 3 sessions of 35 min of training per week at home on an ergocycle. As a result, lower limb muscles will be mainly solicited. These muscles are heterogeneous in terms of deficiency, but this latter is compatible with cycling. The training will be divided in (i) 2 sessions of 30 min aerobic exercises at a constant but moderate (60% of maximal aerobic power, MAP) intensity followed with 5 sets of 10 revolutions at near-maximal intensity and (ii) an interval-training session. This latter session will consist in 5 min warm-up at 40% MAP followed by 5 times 1 min at 80% MAP (recovery = 4 min at 40% MAP) followed by 5 min of active recovery. Over a 2 to 4 weeks initial period, the program will be conducted in the laboratory or at home under the supervision of a coach. Then a systematic supervision of the sessions by the coach will be performed by phone, by using the heart rate recordings and values of Analogic Visual Scale for pain and fatigue.

Other: Physical training

control

OTHER

None intervention

Other: Control

Interventions

Physical training during 24 weeks

Physical training
ControlOTHER

No intervention

control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • facioscapulohumeral dystrophy
  • Being capable of supporting an exercise on ergocycle
  • Social Security regimen affiliated
  • Consent form signed

You may not qualify if:

  • Severe cardiac or respiratory insufficiency
  • Cardiac pacemaker
  • Morbid obesity (BMI upper to 35)
  • Anti platelet therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU de Grenoble

Grenoble, 38000, France

Location

CHU de Saint-Etienne

Saint-Etienne, 42055, France

Location

MeSH Terms

Conditions

Muscular Dystrophy, FacioscapulohumeralMuscular DystrophiesMotor Activity

Interventions

Physical Conditioning, Human

Condition Hierarchy (Ancestors)

Muscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBehavior

Intervention Hierarchy (Ancestors)

ExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Leonard FEASSON, MD-PhD

    CHU de Saint-Etienne

    PRINCIPAL INVESTIGATOR
  • Fawzi KADI, MD-PhD

    Orebro University, Sweden

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2010

First Posted

May 5, 2010

Study Start

October 1, 2010

Primary Completion

January 1, 2015

Study Completion

January 1, 2015

Last Updated

April 1, 2015

Record last verified: 2015-03

Locations